Publications by authors named "S S Berman"
Pharmacists' perceptions of artificial intelligence: A national survey.
J Am Pharm Assoc (2003)
November 2024
Background: Artificial intelligence (AI) is a rapidly growing and evolving field impacting pharmacy research, education, and professional practice. The development and adaptation of AI technologies have the potential to radically shape the future of the pharmacy profession. However, it remains unclear how aware pharmacists are of these technologies or their perceptions regarding current and future utilization.
View Article and Find Full Text PDFBackground: Health care workers (HCWs) are front line responders to the COVID-19 pandemic, but limited data is available for pediatric HCWs, as the research response has largely focused on adult patients and medical personnel that treat these patients.
Methods: We conducted a cross-sectional study of SARS-CoV-2 seroprevalence and risk factors in HCWs at a Children's Hospital in CO, USA from September 2020 to April 2021. Pediatric HCWs were defined as clinical care providers and administrative staff.
Article Synopsis
- * In Alzheimer's disease, these networks become more chaotic, as indicated by a drop in the small-world coefficient, a change linked to cognitive decline throughout the disease's progression.
- * Our study examined the relationship between 10 cerebrospinal fluid protein biomarkers and small-world coefficients in Alzheimer's mutation carriers and non-carriers, finding that certain protein abnormalities indicate early changes in grey matter networks, while markers for inflammation and axonal injury correlate with declining small-world values.
Introduction: We investigated longitudinal associations between self-reported exercise and Alzheimer's disease (AD)-related biomarkers in individuals with autosomal dominant AD (ADAD) mutations.
Methods: Participants were 308 ADAD mutation carriers aged 39.7 ± 10.
Article Synopsis
- The study examines the link between protective lifestyle factors and the age at symptom onset of autosomal dominant Alzheimer disease (ADAD), which is largely influenced by genetics, focusing on how resilience-related experiences may impact this relationship.
- The researchers analyzed data from the Dominantly Inherited Alzheimer Network, assessing both clinical and lifestyle factors in two groups: one looking at general resilience among people showing cognitive stability despite high pathology and another focusing on specific genetic timelines for ADAD.
- Findings from 320 participants indicate variations in age at onset among carriers based on lifestyle and resilience factors, revealing potential avenues for understanding how these influences might delay the onset of symptoms in genetically predisposed individuals.